BARCLAYS PLC - THIRD HARMONIC BIO INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of THIRD HARMONIC BIO INC
ValueSharesWeighting
Q3 2023$23
+21.1%
3,510
-11.4%
0.00%
Q2 2023$19
-29.6%
3,960
-38.8%
0.00%
Q1 2023$27
+92.9%
6,474
+90.7%
0.00%
Q4 2022$14
-100.0%
3,394
-88.2%
0.00%
-100.0%
Q3 2022$546,00028,7500.00%
Other shareholders
THIRD HARMONIC BIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 10,907,859$206,922,00022.84%
Bain Capital Life Sciences Investors, LLC 2,280,082$43,253,0005.16%
COMMODORE CAPITAL LP 1,018,569$19,322,0003.11%
BVF INC/IL 3,501,814$66,429,0002.74%
Orbimed Advisors 5,779,071$109,629,0002.04%
RA Capital Management 3,475,687$65,934,0001.41%
Deep Track Capital, LP 1,268,220$24,058,0001.10%
GENERAL ATLANTIC, L.P. 2,958,762$56,128,0000.66%
Boxer Capital, LLC 570,417$10,821,0000.61%
Monashee Investment Management LLC 40,000$759,0000.28%
View complete list of THIRD HARMONIC BIO INC shareholders